Ophthalmology platform PRISM Vision, a McKesson subsidiary since April 2025, is set to acquire Spectrum Vision Partners from Blue Sea Capital, according to documents reviewed by Healthcare Dealflow, an M&A intelligence platform that tracks deals, trends, and investment activity across the healthcare sector. As of this publication (August 26, 2026), the transaction has not been reported elsewhere and neither party has issued a press release.
Spectrum Vision Partners is a leading eye care MSO headquartered in New York with more than 50 ophthalmology practices, 5+ ambulatory surgery centers, and 140+ doctors across 5 states in the Mid-Atlantic and New England regions. Its flagship practice is OCLI Vision. It has been backed by Blue Sea Capital since 2017.
Healthcare Dealflow identified the pending acquisition through a Certificate of Need determination request filed August 17, 2026 with the Connecticut Office of Health Strategy. The filing was made by a Connecticut facility affiliated with Spectrum Vision Partners and describes both the pre- and post-transaction organizational hierarchy, showing the ownership chain from McKesson through US Oncology and PRISM Vision Holdings to the acquiring organization, NJEYE.
Stay Informed
The Daily Brief covers healthcare M&A deal activity, news, and trends every business day.
Join the investment banks, private equity firms, and advisors who rely on it to stay current.
Subscribe to The Daily Brief →The transaction is the latest in a series of recent private equity-backed MSO exits to strategic acquirers, including:
- Cencora’s acquisition of the retina business of EyeSouth Partners from Olympus Partners (announced March 2026)
- Cencora’s acquisition of OneOncology from TPG (announced December 2025)
- Cardinal Health’s acquisition of Solaris Health from Lee Equity Partners (completed November 2025)
- McKesson’s acquisition of PRISM Vision Holdings from Quad-C Management (completed April 2025)
- Cardinal Health’s acquisition of GI Alliance from Apollo Global Management (completed January 2025)
- Cencora’s acquisition of Retina Consultants of America from Webster Equity Partners (completed January 2025)
Healthcare Dealflow is a healthcare M&A intelligence platform that tracks deal activity, trends and analysis across the healthcare sector for an audience of private equity firms, investment banks, corporate development teams, and transaction advisors. Subscribe to The Daily Brief here.